What Does No Ink on Tumor Mean for Lumpectomy Margins?

When you have a lumpectomy (breast-conserving surgery), the surgeon removes the breast cancer along with a layer of surrounding breast tissue, called the margin. To check if all the cancer was removed from that area, the pathologist paints the outer surface of this tissue with special dyes or ink.

“No ink on tumor” simply means that when the tissue is examined under a microscope, the cancer cells do not touch the painted outer edge. If there is a layer of tissue without cancer between the tumor and the ink—even a microscopic one—the margin is considered “negative” or clear ^{[1] [2]}.

Margin results are a common source of anxiety. While it might seem like taking out as much tissue as possible would be the safest approach, modern breast cancer guidelines are very specific about how much clearance is actually needed, provided you are also having radiation therapy.

The Margin Rules: Invasive Cancer vs. Pure DCIS

The rules for what makes an “adequate” margin depend on the type of breast cancer and your overall treatment plan. The standard guidelines (set by professional medical societies like SSO, ASTRO, and ASCO) apply specifically to patients who will receive whole-breast radiation therapy after their lumpectomy. If your plan does not include radiation, or uses a different type of radiation, your surgeon may recommend different margin widths.

• Invasive Breast Cancer: Invasive cancer means the cancer cells have grown beyond the milk ducts or lobules into surrounding breast tissue. For invasive cancer treated with whole-breast radiation, the consensus standard for an adequate margin is simply “no ink on tumor” ^{[3] [4]}. As long as the cancer cells do not touch the ink, the margin is clear.
• Pure DCIS: Ductal Carcinoma In Situ (DCIS) is non-invasive breast cancer confined to the milk ducts. While a DCIS margin with no ink on it is technically “negative,” the consensus guideline recommends a slightly wider adequate margin of 2 millimeters (about 1/16 of an inch) for pure DCIS treated with whole-breast radiation ^[5].
• Mixed Invasive Cancer and DCIS: If your tumor has both invasive cancer and associated DCIS, the rule for invasive cancer (“no ink on tumor”) generally applies to both components. A DCIS margin of less than 2 mm is not automatically a reason for another surgery when invasive cancer is also present ^[6].

Why Wider Margins Don’t Mean Better Results

In the past, surgeons often tried to take a very wide margin of tissue (sometimes 10 millimeters or more) just to be safe. However, years of data show that for invasive cancer, taking more tissue to get a wider negative margin does not improve local control (keeping the cancer from coming back in that breast) ^{[3] [7]}. Similarly, for pure DCIS, margins wider than 2 millimeters do not lower recurrence rates any further ^[8].

There is a “plateau” in the benefit of removing tissue ^{[9] [10]}. A clear margin is just one favorable result in a larger treatment plan. Once the margin is adequate, your risk of microscopic cancer cells remaining elsewhere in the breast is managed by other treatments, such as radiation therapy, and (when appropriate for your tumor biology) hormone-blocking pills or chemotherapy ^{[11] [12] [13]}. Removing extra breast tissue does not fight these microscopic risks, but it can increase the chances of cosmetic deformity ^[14].

When Is Another Surgery (Re-excision) Needed?

If cancer cells do touch the ink, this is a positive margin. A positive margin generally prompts a discussion about a second surgery, called a re-excision, to remove more tissue from that specific area, or sometimes a mastectomy ^{[2] [5]}. Radiation is not ordinarily used to substitute for removing a positive margin.

However, a surgeon might also discuss further evaluation or a re-excision if:

• You have extensive DCIS: An extensive intraductal component (EIC) means there is a large amount of DCIS mixed with invasive cancer. While EIC alone does not mandate another surgery if margins are clear, it is a risk factor for residual disease that makes your team look very closely at close margins ^[15].
• Your pure DCIS margin is less than 2mm: A negative margin under 2mm is not an automatic reason for a second surgery. Your doctor will weigh this against your age, tumor features, and imaging to make an individualized decision ^{[5] [3]}.
• Calcifications remain on imaging: Microcalcifications are tiny calcium deposits seen on a mammogram. If a post-surgery mammogram shows suspicious microcalcifications still inside the breast near the surgical cavity (the space left by the lumpectomy), further imaging, biopsy, or a re-excision may be needed to evaluate them ^{[16] [17]}.
• The tissue was hard to evaluate: Sometimes a tissue specimen is fragmented, or its orientation (knowing exactly which side faced up, down, left, or right) is unclear. This usually prompts a careful review by the pathology and surgical teams to decide if the margins can be trusted or if more tissue should be removed ^{[18] [19]}.

Every breast cancer is unique. The most important step is to review your specific pathology report and radiation plan with your multidisciplinary care team, which may include your surgeon, radiation oncologist, and medical oncologist.